Medscape CME Internet-Based Activity
This announcement has 1 attachment:
Brain Glucose Hypometabolism, Ketosis, and Alzheimer Disease:
From Controversy to Consensus CME
This activity is intended for neurologists, primary care physicians, and other healthcare practitioners involved in the diagnosis and treatment of Alzheimer disease.
- Identify and evaluate the results of clinical research on brain glucose hypometabolism as a pathologic characteristic of Alzheimer disease
- Describe the rationale for treatment to address brain glucose hypometabolism
- Compare and contrast strategies to induce ketosis to address brain glucose hypometabolism